iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)
iBio, Inc. shares surged 39% Monday to close at $1.67 on heavy volume, lifting its market value to about $37.5 million. The stock traded higher pre-market Tuesday, with quotes between $1.76 and $1.81. The company reported $49.6 million in cash after a recent offering and says this will fund operations into late 2027. Lead obesity drug candidate IBIO-610 has shown fat-selective weight loss in animal studies.
